FGFR4 and polycystic ovary syndrome: Therefore, we first unearthed the molecular pathogenesis of PCOS using proteomics analysis and then investigated the effects of FGF19 on PCOS and its associated molecular mechanisms, with an emphasis on the regulatory action of the FGFR4-ERK-NRF2 pathway.